Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Kliogest N" (48)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
(Codice) 39 products
WHO-DDD
IP
CI
CM
Gabapentin Viatris 100 mg
50
7.69
17.05
10 %
Capsules: Gabapentinum 100 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Gabapentin Viatris 100 mg
100
13.53
27.85
10 %
Capsules: Gabapentinum 100 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Gabapentin Viatris 300 mg
50
16.59
35.50
10 %
Capsules: Gabapentinum 300 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Gabapentin Viatris 300 mg
100
33.16
54.50
10 %
Capsules: Gabapentinum 300 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Gabapentin Viatris 400 mg
50
23.86
43.85
10 %
Capsules: Gabapentinum 400 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Gabapentin Viatris 400 mg
100
45.00
68.15
10 %
Capsules: Gabapentinum 400 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
Azacitidin Stada 100 mg
PR
PR
k.A.
Powder for injection suspension: Azacitidinum 100 mg
Spirig HealthCare AG
A
FB
G
IP
Azacitidin Stada 150 mg
PR
PR
k.A.
Powder for injection suspension: Azacitidinum 150 mg
Spirig HealthCare AG
A
FB
G
IP
Ph
Ginkgo-Mepha 240 mg
30
PR
PR
k.A.
Coated tablets: Ginkgonis Extractum Siccum Raffinatum et Quantificatum (Ginkgo Biloba l., Folium) 240 mg
Mepha Pharma AG
B
FB
G
IP
Ph
Ginkgo-Mepha 240 mg
60
PR
PR
k.A.
Coated tablets: Ginkgonis Extractum Siccum Raffinatum et Quantificatum (Ginkgo Biloba l., Folium) 240 mg
Mepha Pharma AG
B
FB
G
IP
Ph
Ginkgo-Mepha 240 mg
90
PR
PR
k.A.
Coated tablets: Ginkgonis Extractum Siccum Raffinatum et Quantificatum (Ginkgo Biloba l., Folium) 240 mg
Mepha Pharma AG
B
FB
G
IP
CI
Depakine Chrono 300
-
T
100 Tablet(s)
12.73
26.95
20 %
Divitabs: 2 Active Agents
Sanofi-Aventis
(Suisse) SA
B / SL / SO
FB
G
IP
Cisplatin Sandoz 10 mg/20 ml
Durchstechflasche(n)
14.68
29.20
10 %
Concentrate for infusion: Cisplatinum 10mg / 20ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
Cisplatin Sandoz 50
mg/100 ml
Durchstechflasche(n)
58.90
84.10
10 %
Concentrate for infusion: Cisplatinum 50mg / 100ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Gabapentin-Mepha 300 mg
50 Capsule(s)
16.98
35.95
10 %
Capsules: Gabapentinum 300 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Gabapentin-Mepha 300 mg
100 Capsule(s)
33.33
54.70
10 %
Capsules: Gabapentinum 300 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
VEYVONDI 650 IE
650
532.84
587.75
10 %
Lyophilisate and solvent: Vonicogum Alfa 650 UI
Takeda Pharma AG
B / SL
FB
G
L
IP
VEYVONDI 1300 IE
1300
1065.68
1134.45
10 %
Lyophilisate and solvent: Vonicogum Alfa 1300 UI
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
Renvela 2.4 g
60 Sachet(s)
141.67
179.20
10 %
Soluble Powder: Sevelameri Carbonas 2400 mg
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
L
IP
Rixathon 500 mg/50 ml
1051.32
1215.70
10 %
Concentrate for infusion: Rituximabum 500mg / 50ml
Sandoz
Pharmaceuticals AG
●
A / SL
FB
G
L
IP
Rixathon 100 mg/10 ml
2
421.97
501.30
10 %
Concentrate for infusion: Rituximabum 100mg / 10ml
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
Vegzelma 100 mg/4 ml
257.57
312.40
10 %
Concentrate for infusion: Bevacizumabum 100mg / 4ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
L
IP
Vegzelma 400 mg/16 ml
962.84
1118.60
10 %
Concentrate for infusion: Bevacizumabum 400mg / 16ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
L
IP
CI
Ph
Ginkgo-Mepha 80 mg
60 Tablet(s)
21.02
40.55
10 %
Coated tablets: Ginkgonis Extractum Siccum Raffinatum et Quantificatum (Ginkgo Biloba l., Folium) 80 mg
Mepha Pharma AG
B / SL
FB
G
L
IP
CI
Ph
Ginkgo-Mepha 80 mg
120 Tablet(s)
37.00
58.95
10 %
Coated tablets: Ginkgonis Extractum Siccum Raffinatum et Quantificatum (Ginkgo Biloba l., Folium) 80 mg
Mepha Pharma AG
B / SL
FB
G
L
IP
CI
Ph
Ginkgo-Mepha 120 mg
60 Tablet(s)
28.70
49.40
10 %
Coated tablets: Ginkgonis Extractum Siccum Raffinatum et Quantificatum (Ginkgo Biloba l., Folium) 120 mg
Mepha Pharma AG
B / SL
FB
G
L
IP
CI
Ph
Ginkgo-Mepha 120 mg
120 Tablet(s)
50.51
74.45
10 %
Coated tablets: Ginkgonis Extractum Siccum Raffinatum et Quantificatum (Ginkgo Biloba l., Folium) 120 mg
Mepha Pharma AG
B / SL
FB
G
L
IP
PP
Herceptin subkutan
600mg/5ml
1484.04
1690.75
10 %
Lösung zur subkutanen Injektion: Trastuzumabum 600mg / 5ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
Inflectra 100 mg
Durchstechflasche(n)
495.81
586.15
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Infliximabum 100 mg
Pfizer AG
A / SL
FB
G
L
IP
Ogivri 150 mg
456.84
541.40
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mg
Medius AG
A / SL
FB
G
IP
CI
V/S
Comirnaty®
Original/Omicron BA.1
15/15 µg pro Dosis
gebrauchsfertige
Injektionsdispersion für
Personen ab 18 Jahren
10
PR
PR
k.A.
2 Active Agents
Pfizer AG
B
FB
G
IP
CI
V/S
Comirnaty®
Original/Omicron BA.1
15/15 µg pro Dosis
gebrauchsfertige
Injektionsdispersion für
Personen ab 18 Jahren
195
PR
PR
k.A.
2 Active Agents
Pfizer AG
B
FB
G
IP
CI
Bilaxten 6 mg / ml
5 ml
PR
PR
k.A.
Eye drops: Bilastinum 6 mg/ml
A. Menarini GmbH
B
FB
G
IP
Renvela 0.8 g
90
PR
PR
k.A.
Soluble Powder: Sevelameri Carbonas 800 mg
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
Rixathon 500 mg/50 ml
2
PR
PR
k.A.
Concentrate for infusion: Rituximabum 500mg / 50ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Rixathon 100 mg/10 ml
3
PR
PR
k.A.
Concentrate for infusion: Rituximabum 100mg / 10ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Xevudy
PR
PR
k.A.
Concentrate for infusion: Sotrovimabum 500mg / 8ml
GlaxoSmithKline AG
A
FB
G
IP
CI
V/S
Comirnaty
195
PR
PR
k.A.
Konzentrat zur Herstellung einer Injektionsdispersion: Tozinameranum 225 µg
Pfizer AG
B
FB
G
IP
Mylotarg 5 mg
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Gemtuzumabum Ozogamicinum 5 mg
Pfizer AG
A
FB
G
Norethisterone and Estrogen (G03FA01) 9 products
WHO-DDD
DrugBank.ca
IP
CI
Estalis 50/140
8 plaster(s)
10.55
20.35
10 %
Transdermal patch: 2 Active Agents
Sandoz
Pharmaceuticals AG
B / SL
FB
G
IP
CI
Estalis 50/140
24 plaster(s)
27.46
47.95
10 %
Transdermal patch: 2 Active Agents
Sandoz
Pharmaceuticals AG
●
B / SL
FB
G
IP
CI
Estalis 50/250
8 plaster(s)
11.63
25.70
10 %
Transdermal patch: 2 Active Agents
Sandoz
Pharmaceuticals AG
B / SL
FB
G
IP
CI
Estalis 50/250
24 plaster(s)
32.44
53.70
10 %
Transdermal patch: 2 Active Agents
Sandoz
Pharmaceuticals AG
●
B / SL
FB
G
IP
CI
Systen Conti
8 plaster(s)
12.04
26.15
10 %
Transdermal patch: 2 Active Agents
Future Health Pharma
GmbH
B / SL
FB
G
IP
CI
Systen Conti
24 plaster(s)
31.28
52.35
10 %
Transdermal patch: 2 Active Agents
Future Health Pharma
GmbH
B / SL
FB
G
IP
CI
Systen Sequi
8 plaster(s)
7.66
17.00
10 %
Transdermal patch: Estradiolum Hemihydricum 3.2 mg
Transdermal patch: 2 Active Agents
Future Health Pharma
GmbH
B / SL
FB
G
IP
CI
Activelle
28 Tablet(s)
8.38
17.85
10 %
Coated tablets: 2 Active Agents
Novo Nordisk Pharma AG
B / SL
FB
G
IP
CI
Kliogest N
28 Tablet(s)
8.20
17.65
10 %
Coated tablets: 2 Active Agents
Novo Nordisk Pharma AG
B / SL
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2024
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
